ಬಾಯಿಯ ಕ್ಯಾನ್ಸರ್
This study involved people with oral cancer and looked at how well a new saliva-based testing device could tell if their treatment was working, if the cancer might come back, and how well they were recovering compared to the usual methods like biopsies and medical scans.
ಆಸ್ಪತ್ರೆಯನ್ನು ಸಂಪರ್ಕಿಸಿ
ನೋಂದಣಿಯು ಈ ಆಸ್ಪತ್ರೆಯನ್ನು ಪ್ರಯೋಗದ ಮುಖ್ಯ ಸಂಪರ್ಕವಾಗಿ ಹೆಸರಿಸಿದೆ. ಯಾವ ಆಸ್ಪತ್ರೆಗಳು ರೋಗಿಗಳನ್ನು ತೆಗೆದುಕೊಳ್ಳುತ್ತಿವೆ ಎಂದು ಅವರನ್ನು ಕೇಳಿ.
ರಿಜಿಸ್ಟ್ರಿ ಸಾರಾಂಶ (ತಾಂತ್ರಿಕ)
A Prospective, Multi-Centre, Performance Evaluation Study to Determine the Accuracy of Saliscope, A Saliva Based Companion Diagnostic Assay in Predicting Chemotherapeutic Response, Relapse Propensity and Immunotherapeutic Efficacy in Oral Squamous Cell Carcinoma Patients, in Comparison to Conventional Histopathology Evaluation and RECIST Guidelines - NIL
Sponsor: Genoscope Private Limited
CTRI, India's trial registry ನಲ್ಲಿ CTRI/2026/06/112560
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 5 Oct 2026 · read by us 5 Nov 2026